We are live on ! Find out more
OC

Oppenheimer & Co Portfolio holdings

AUM $9.37B
1-Year Est. Return 36.4%
This Fund
S&P 500
This Quarter Est. Return
-13.53%
1 Year Est. Return
+36.4%
3 Year Est. Return
+114.29%
5 Year Est. Return
+137.63%
10 Year Est. Return
+514.16%
AUM
$4.65B
AUM Growth
-$902M
Cap. Flow
-$55.6M
Cap. Flow %
-1.2%
Top 10 Hldgs %
17.2%
Holding
1,576
New
113
Increased
560
Reduced
639
Closed
173

Sector Composition

Rank Sector Weight
1 Technology 16.34%
2 Healthcare 11.48%
3 Financials 11.22%
4 Industrials 8.07%
5 Consumer Discretionary 7.5%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ABB
501
DELISTED
ABB Ltd
ABB
$1.75M 0.04%
65,459
-9,484
-13% -$282K
ETRN
502
DELISTED
Equitrans Midstream Corporation Common Stock
ETRN
$1.75M 0.04%
274,880
+60,730
+28% +$469K
ULTA icon
503
Ulta Beauty
ULTA
$23B
$1.75M 0.04%
4,530
-1,295
-22% -$515K
MKC icon
504
McCormick & Company Non-Voting
MKC
$13.9B
$1.74M 0.04%
20,955
-790
-4% -$74.8K
FE icon
505
FirstEnergy
FE
$28B
$1.74M 0.04%
45,386
-22,778
-33% -$972K
AJRD
506
DELISTED
Aerojet Rocketdyne Holdings
AJRD
$1.74M 0.04%
42,894
+450
+1% +$18.2K
EG icon
507
Everest Group
EG
$14.4B
$1.74M 0.04%
6,195
+188
+3% +$53.1K
AME icon
508
Ametek
AME
$55.9B
$1.73M 0.04%
15,705
+2,775
+21% +$337K
BTX
509
BlackRock Technology and Private Equity Term Trust
BTX
$963M
$1.72M 0.04%
216,497
+39,646
+22% +$356K
DD icon
510
DuPont de Nemours
DD
$19.1B
$1.71M 0.04%
24,531
-127
-0.5% -$10.4K
VIGI icon
511
Vanguard International Dividend Appreciation ETF
VIGI
$9.1B
$1.71M 0.04%
24,932
+14,937
+149% +$1.09M
EEMV icon
512
iShares MSCI Emerging Markets Min Vol Factor ETF
EEMV
$3.47B
$1.71M 0.04%
30,806
+230
+0.8% +$13.3K
GVI icon
513
iShares Intermediate Government/Credit Bond ETF
GVI
$3.77B
$1.71M 0.04%
16,150
-518
-3% -$55K
RSPM icon
514
Invesco S&P 500 Equal Weight Materials ETF
RSPM
$188M
$1.69M 0.04%
+54,575
New +$1.92M
FNX icon
515
First Trust Mid Cap Core AlphaDEX Fund
FNX
$1.39B
$1.68M 0.04%
20,121
+7,204
+56% +$662K
IJK icon
516
iShares S&P Mid-Cap 400 Growth ETF
IJK
$10.8B
$1.68M 0.04%
26,376
-1,067
-4% -$74.9K
LEVI icon
517
Levi Strauss
LEVI
$9.48B
$1.68M 0.04%
102,825
+1,617
+2% +$29.2K
VICI icon
518
VICI Properties
VICI
$29.2B
$1.67M 0.04%
55,963
-1,962
-3% -$57.9K
ROP icon
519
Roper Technologies
ROP
$38.8B
$1.64M 0.04%
4,157
-493
-11% -$214K
LTHM
520
DELISTED
Livent Corporation
LTHM
$1.63M 0.04%
71,996
+7,654
+12% +$197K
BIIB icon
521
Biogen
BIIB
$29.8B
$1.63M 0.04%
7,982
-231
-3% -$47.2K
ON icon
522
ON Semiconductor
ON
$31.3B
$1.62M 0.03%
32,156
-8,950
-22% -$499K
JKHY icon
523
Jack Henry & Associates
JKHY
$11.1B
$1.62M 0.03%
8,987
+5
+0.1% +$936
LH icon
524
Labcorp
LH
$24.9B
$1.61M 0.03%
7,999
+1,096
+16% +$234K
BSX icon
525
Boston Scientific
BSX
$72B
$1.61M 0.03%
43,163
+16,019
+59% +$652K

Similar funds

Oppenheimer & Co's Q2 2022 Portfolio in Review

As of Q2 2022, Oppenheimer & Co held 1,576 positions worth $4.65B, down 16% from $5.55B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Oppenheimer & Co's Q2 2022 filing shows 113 new, 560 increased, 639 reduced and 173 closed positions. Its largest new stake was Warner Bros: 379,857 shares worth $5.1M. The largest sale was abrdn Physical Gold Shares ETF, an estimated $12.8M.

By sector, the portfolio is most concentrated in Technology at 16% of assets, down from 18% a quarter earlier, followed by Healthcare and Financials.

  • Oppenheimer & Co's largest Q2 2022 buy was Warner Bros: 379,857 shares worth $5.1M.
  • Oppenheimer & Co added most to State Street SPDR Bloomberg Short Term High Yield Bond ETF in Q2 2022, an estimated $11.4M increase.
  • Oppenheimer & Co's biggest Q2 2022 reduction was Apple, cutting an estimated $7.91M.
  • Oppenheimer & Co fully exited abrdn Physical Gold Shares ETF in Q2 2022, selling an estimated $12.8M.
  • Oppenheimer & Co's ten largest holdings make up 17% of its $4.65B portfolio in Q2 2022.
  • Oppenheimer & Co opened 113 new positions and closed 173 in Q2 2022.
  • Oppenheimer & Co's portfolio value fell 16% quarter-over-quarter to $4.65B.

Based on Oppenheimer & Co's 13F filing for Q2 2022, filed 8 Aug 2022.